Table 1. Baseline characteristics of subjects randomized to active or placebo intervention.
Active | Placebo | |
---|---|---|
Number | 19 | 9 |
Median age, months | 84 (38-126) | 69 (28-114) |
Sex | 9 male, 10 female | 9 male |
Race | 18 white, 1 biracial | 9 white |
Subjects with asthma | 13 (68%) | 7 (78%) |
Subjects with atopic dermatitis | 14 (74%) | 4 (44%) |
Subjects with allergic rhinitis | 15 (79%) | 8 (89%) |
Subjects with other food allergy | 14 (74%) | 8 (89%) |
Median baseline peanut IgE, kU/L* | 106 (31-685) | 57 (20-188) |
Median baseline titrated SPT, mm | 7 (5.5-15) | 7 (5.5-13) |
p=0·02
IgE = immunoglobulin E, SPT = skin prick test